公司概覽
業務類別 Medical Instruments & Supplies
業務概覽 Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
公司地址 410 North Scottsdale Road, Suite 1300, Tempe, AZ, USA, 85288
電話號碼 +1 602 742-2000
傳真號碼 +1 408 470-1010
公司網頁 https://www.aligntech.com
員工數量 20290
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Joseph M. Hogan President, Chief Executive Officer and Director 美元 1.40M 27/02/2026
Mr. Stuart A. Hockridge Executive Vice President, Global Human Resources 美元 518.46K 27/02/2026
Mr. John F Morici Principal Accounting Officer, Chief Financial Officer and Executive Vice President, Global Finance 美元 675.39K 27/02/2026
Ms. Julie Ann Coletti Executive Vice President, Chief Legal Officer and Chief Regulatory Officer 美元 597.69K 27/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. Charles Raymond Larkin, Jr Chairman of the Board 27/02/2026
Mr. Britt J. Vitalone Director 27/02/2026
Mr. Joseph S. Lacob Independent Director 27/02/2026
Ms. Susan E. Siegel Independent Director 27/02/2026
Mr. George J. Morrow Independent Director 27/02/2026
Mr. Joseph M. Hogan President, Chief Executive Officer and Director 27/02/2026
Mr. Kevin T. Conroy Independent Director 27/02/2026
Ms. Andrea L. Saia Independent Director 27/02/2026
Mr. Kevin J. Dallas Independent Director 27/02/2026
Ms. Anne M. Myong Independent Director 27/02/2026
Ms. Mojdeh Poul Independent Director 27/02/2026
 
所屬ETF (更新日期: 07/03/2026 04:30)
代號 名稱 佔比% 持有日期
CVMCCalvert US Mid-Cp Cor Rspnb ETF0.001%27/02/2026
TMEDT. Rowe Price Health Care ETF0.001%28/02/2026
VSLUApplied Finance Valuation LgCp ETF0.001%27/02/2026
LGHTLangar Global HealthTech ETF0.001%27/02/2026
HCMTDirexion HCM Tactical EnhU.S.EqStratETF0.001%26/02/2026
AVMVAvantis U.S. Mid Cap Value ETF0.001%28/02/2026
SPXTProShares S&P 500® ex-Technology0.001%27/02/2026
QQQSInvesco NASDAQ Future Gen 200 ETF0.001%27/02/2026
PBPInvesco S&P 500 BuyWrite ETF0.001%27/02/2026
SPGMState Street® SPDR® Ptf MSCIGlbStkMktETF0.001%27/02/2026
FABFirst Trust Multi Cap Val AlphaDEX® ETF0.0005%26/02/2026
MDEVFirst Trust Indxx Global Mdcl Dvcs ETF0.0004%26/02/2026
PEXLPacer US Export Leaders ETF0.0004%27/02/2026
BRCEMFS Blended Research Core Equity ETF0.0004%27/02/2026
JDOCJPMorgan Healthcare Leaders ETF0.0004%27/02/2026
TPLETimothy Plan US Large/Mid Cp Cr Enh ETF0.0004%02/10/2025
SPUUDirexion Daily S&P 500® Bull 2X ETF0.0003%26/02/2026
QARPXtrackers Russell 1000 US QARP ETF0.0003%26/02/2026
JUSAJPMorgan ActiveBuilders US Lg Cp Eq ETF0.0002%31/08/2023
DEUSXtrackers Russell US Multifactor ETF0.0002%26/02/2026
  1    2    3    4    5    6   7    8    9    10    11    12    13    14  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.